280 related articles for article (PubMed ID: 6630761)
1. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.
Kay GN; Plumb VJ; Arciniegas JG; Henthorn RW; Waldo AL
J Am Coll Cardiol; 1983 Nov; 2(5):806-17. PubMed ID: 6630761
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
[TBL] [Abstract][Full Text] [Related]
4. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.
Lewis BH; Antman EM; Graboys TB
J Am Coll Cardiol; 1983 Sep; 2(3):426-36. PubMed ID: 6192159
[TBL] [Abstract][Full Text] [Related]
5. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
[TBL] [Abstract][Full Text] [Related]
6. Drug therapy for torsade de pointes.
Banai S; Tzivoni D
J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
[TBL] [Abstract][Full Text] [Related]
7. A practical approach to torsade de pointes.
Roden DM
Clin Cardiol; 1997 Mar; 20(3):285-90. PubMed ID: 9068917
[TBL] [Abstract][Full Text] [Related]
8. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced torsade de pointes. Incidence, management and prevention.
Faber TS; Zehender M; Just H
Drug Saf; 1994 Dec; 11(6):463-76. PubMed ID: 7727055
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.
Roden DM; Woosley RL; Primm RK
Am Heart J; 1986 Jun; 111(6):1088-93. PubMed ID: 3716982
[TBL] [Abstract][Full Text] [Related]
11. Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.
Gilmour RF; Riccio ML; Locati EH; Maison-Blanche P; Coumel P; Schwartz PJ
J Am Coll Cardiol; 1997 Jul; 30(1):209-17. PubMed ID: 9207644
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmic storm: Short-coupled variant torsade de pointes.
Godinho AR; Frutuoso C; Vasconcelos M; Dias P; Garcia R; Pinho T; Araújo V; Maciel MJ
Rev Port Cardiol; 2016 May; 35(5):307.e1-5. PubMed ID: 27132471
[TBL] [Abstract][Full Text] [Related]
13. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
[TBL] [Abstract][Full Text] [Related]
14. Recurrent torsade de pointes type ventricular tachycardia in intracranial hemorrhage.
Sen S; Stober T; Burger L; Anstätt T; Rettig G
Intensive Care Med; 1984; 10(5):263-4. PubMed ID: 6491039
[TBL] [Abstract][Full Text] [Related]
15. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.
Halkin A; Roth A; Lurie I; Fish R; Belhassen B; Viskin S
J Am Coll Cardiol; 2001 Oct; 38(4):1168-74. PubMed ID: 11583899
[TBL] [Abstract][Full Text] [Related]
16. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
[TBL] [Abstract][Full Text] [Related]
17. Torsade de pointes.
Roden DM
Clin Cardiol; 1993 Sep; 16(9):683-6. PubMed ID: 7902224
[TBL] [Abstract][Full Text] [Related]
18. Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.
Uvelin A; Pejaković J; Mijatović V
J Anesth; 2017 Jun; 31(3):413-423. PubMed ID: 28229241
[TBL] [Abstract][Full Text] [Related]
19. [Iatrogenic torsade de pointes induced by thioridazine].
Paoloni P; Ciliberti D; Blasi N; Capone P
Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
[TBL] [Abstract][Full Text] [Related]
20. Torsade de pointes and syncopal attacks in a 26-year old woman with congenital complete heart block and prolonged QT interval.
Quek DK; Ong SB
Singapore Med J; 1990 Apr; 31(2):185-8. PubMed ID: 2371586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
